A randomized, double‐blind, placebo‐controlled trial of probiotics to reduce the severity of oral mucositis induced by chemoradiotherapy for patients with nasopharyngeal carcinoma

Abstract

A probiotic combination significantly enhances the immune response of patients and reduces the severity of OM through modification of gut microbiota.